Overview

Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
0
Participant gender:
All
Summary
Subjects will be asked to participate in a four day research study of the immune system effects and safety of short-term acute dosing of Cold-fX. The purpose of the study is to determine the effects of acute dosing of Cold-fX for 3 days on the immune system compared to a placebo (dummy pill). Safety of the acute dosing will be determined through various blood tests carried out during the study.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
CV Technologies
Criteria
Inclusion Criteria:

- General good health

- Willing to adhere to the requirements of the protocol, including availability for
follow-up visits

- Willing and able to sign written informed consent

Exclusion Criteria:

- Individuals with known HIV infection

- Individuals with malignancy

- Individuals with a history or symptoms of unstable cardiovascular disease

- Individuals with renal abnormalities

- Individuals having a history or symptoms of pulmonary disease

- Individuals having acute or active chronic liver disease

- Individuals having neurologic or psychiatric disease

- Individuals having active tuberculosis

- Individuals having multiple sclerosis

- Individuals having bleeding disorders

- Individuals with planned surgery over the course of the trial or having had major
surgery in the past 6 mo.

- Individuals with a history of alcohol/drug abuse

- Pregnant and lactating women

- Individuals on prescribed medication with the exception of oral contraceptives

- Individuals with Crohn's disease, Lupus, Rheumatoid arthritis, Colitis or any other
auto-immune disease

- Individuals using natural health products or dietary supplements for 2 weeks prior and
during the trial

- Individuals having allergies to ginseng or to any known component of the drug product
or placebo

- Smokers (smoking > 10 cigarettes/day)

- Alcoholics (drinking > 10 drinks/week)